Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Moderna Therapeutics
161 First Street, Suite 2A
Cambridge, MA 2142
Phone: 617-714-6500
www.modernatx.com

Moderna is pioneering messenger RNA Therapeutics™, an entirely new treatment modality that enables the body to produce therapeutic proteins in vivo. Moderna is using this approach to develop first-ever treatments for a wide range of diseases that cannot be addressed today using existing technologies, and to drastically reduce the time and expense associated with creating therapeutic proteins using recombinant technologies. The company has demonstrated proof-of-concept using messenger RNA Therapeutics for a variety of indications and is moving multiple programs into the clinic.

Key Contact
Name
Stephane Bancel
Title
CEO
Funding Events

Date
Amount
Type
Investors
12/06/12 $40,000,000 Flagship Ventures
11/20/13 $110,000,000 Flagship Ventures
01/06/15 $450,000,000 Alexion Pharmaceuticals
AstraZeneca
Invus
RA Capital
Viking Global Investors
Wellington Management Company
02/02/18 $500,000,000 Abu Dhabi Investment Authority
Alexandria Real Estate Equities
ArrowMark Partners
BB Biotech Ventures
EDBI
Fidelity Management & Research Company
Julius Baer
Pictet
Sequoia Capital
Viking Global Investors